Skip to content
Screener

Polaryx Therapeutics, Inc. PLYX Current ratio

Current ratio at other companies

BioMarin Pharmaceuticals logo
BioMarin PharmaceuticalsBMRN
2.4×-3.2×
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
5.2×-2.7×
Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
1.2×-0.8×
PVL
Palvella TherapeuticsPVLA
28.9×+20.0×
XER
Xeris Biopharma Holdings, Inc.XERS
1.4×-0.5×
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
18.3×-2.7×

Other financials

Income statement

See full
Operating income-$2.0M+61.2%
Net income-$2.5M+49.6%
EPS (diluted)-$0.05+54.5%

Balance sheet

See full
Cash & equivalents$3.1M+1,132%
Total equity$2.5M-41.5%
Total assets$3.5M—

Cash flow

See full
Operating cash flow-$2.1M-191%

Valuation

See full
Market cap$111.66M-89.5%

Returns & leverage

See full
Return on equity-1,209.8%—